Skip to content

Evaluation of a pseudo-ceramide containing formulation

A Study on skin improving effects of a pseudo-ceramide containing formulation for sensitive skin - Evaluation of a pseudo-ceramide containing formulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000042427
Enrollment
55
Registered
2020-11-16
Start date
2020-11-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Apply the water based model lotion and the model emulsion on facial skin twice a day for a week. After that, apply the pseudo-ceramide containing formulation in addition to above model lotions and em

Sponsors

Kao Corporation
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Females who are 20-59 years old 2. Subjects who have sensitive skin consciousness. 3. Subjects who have dry skin consciousness. 4. Subjects who apply to one or more following questions. a. I need to use skin care products twice a day on my face. b. Cosmetics and medicines have caused redness, drying and irritation to my skin. c. I use cosmetic products for sensitive skin. 5. Subjects who use face wash at least 5 days a week 6. Subjects who use lotion or all-in-one cosmetics at least 5 days a week

Exclusion criteria

Exclusion criteria: 1. Subjects who are pregnancy, lactation, or subjects who may become pregnant very soon. 2. Subjects with serious underlying diseases. 3. Subjects who have clear skin symptoms at the test site. 4. Subjects who are currently undergoing hospital treatment with atopic dermatitis 5. Subjects who have had atopic dermatitis symptoms in their face within the present or past year 6. Subjects who are currently treating the skin of the face 7. Subjects who are currently using external drugs (prescription drugs, over-the-counter drugs) on the skin of the face 8. Subjects who are currently participating in product monitor surveys involving testing of the use of other drugs or with the use of quasi-drugs, cosmetics, and facial devices 9. Subjects who are determined to be not appropriate by investigator.

Design outcomes

Primary

MeasureTime frame
Evaluation of transepidermal water loss, stratum corneum water content and dermatological assessment after treatments for 1 or 2 weeks.

Secondary

MeasureTime frame
Evaluation of the skin surface images, questionnaire survey and VAS after treatments for 1 or 2 weeks.

Countries

Japan

Contacts

Public ContactSeri Akiyama

Kao Corporation R&D Skin Care Products Research

akiyama.seri@kao.com0465-34-0559

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026